137
edits
Changes
Myeloid Neoplasms with Germline Predisposition (view source)
Revision as of 11:47, 7 January 2021
, 11:47, 7 January 2021→Additional Information
==Additional Information==
==Additional Information==
*''ANKRD26 (OMIM: 610855)'' has been associated with thrombocytopenia 2 (OMIM: 188000, <nowiki>https://www.omim.org/entry/188000</nowiki>).
*''ANKRD26 (OMIM: 610855)'' has been associated with thrombocytopenia 2 ([https://www.omim.org/entry/188000 OMIM: 188000)]
*''CEBPA (OMIM: 116897)'' has been associated with acute myeloid leukemia (OMIM: 601626, <nowiki>https://www.omim.org/entry/601626</nowiki>).
*''CEBPA (OMIM: 116897)'' has been associated with acute myeloid leukemia ([https://www.omim.org/entry/601626 OMIM: 601626])
*''DDX41'' ''(OMIM: 608170)'' has been associated with susceptibility to multiple types of familial myeloproliferative/lymphoproliferative neoplasms (OMIM: 616871, <nowiki>https://www.omim.org/entry/616871</nowiki>).
*''DDX41'' ''(OMIM: 608170)'' has been associated with susceptibility to multiple types of familial myeloproliferative/lymphoproliferative neoplasms (OMIM: 616871, <nowiki>https://www.omim.org/entry/616871</nowiki>).
*''ETV6'' ''(OMIM: 600618)'' has been associated with thrombocytopenia 5 (OMIM: 616216, <nowiki>https://www.omim.org/entry/616216</nowiki>).
*''ETV6'' ''(OMIM: 600618)'' has been associated with thrombocytopenia 5 (OMIM: 616216, <nowiki>https://www.omim.org/entry/616216</nowiki>).